Smiths Medical 21-8050-24 - PORT INFUSION DUAL LUMEN TITANIUM PORT DETACHED 10.2FR SILICONE CATHETER

The Smiths Medical 21-8050-24 Port Infusion Dual Lumen Titanium Port with Detached 10.2Fr Silicone Catheter is designed for reliable vascular access in clinical infusion therapy. Built with a durable titanium port body and a flexible silicone catheter, this device supports long-term access needs where repeated medication delivery, fluid administration, blood sampling, or infusion therapy may be required under professional medical supervision.

This dual lumen port configuration allows clinicians to manage compatible therapies through separate access pathways, helping improve workflow efficiency in settings that require dependable implanted port performance. Its detached catheter design supports procedural flexibility during placement, while the 10.2Fr silicone catheter is intended to provide smooth handling and patient-focused performance when used according to facility protocols and product instructions.

Key Benefits

The Smiths Medical 21-8050-24 dual lumen titanium port offers a strong combination of durability, clinical flexibility, and dependable access support for healthcare environments. The titanium construction helps provide structural strength for implanted use, while the silicone catheter offers flexibility for vascular access applications.

• Dual lumen design supports separate infusion pathways for compatible therapies.
• Titanium port body provides durable construction for long-term implanted access.
• Detached 10.2Fr silicone catheter allows placement flexibility during implantation.
• Designed for use in professional infusion, oncology, vascular access, and specialty care settings.
• Supports repeated access when used with appropriate non-coring needles and approved clinical technique.
• Helps streamline care for patients requiring ongoing infusion therapy or vascular access management.

Compatibility and Applications

The Smiths Medical 21-8050-24 port infusion system is intended for use by trained healthcare professionals in clinical environments where implanted vascular access is required. It may be used in hospitals, outpatient infusion centers, oncology departments, specialty clinics, and other medical settings that manage patients requiring repeated venous access.

Typical applications may include administration of compatible medications, fluids, parenteral therapies, blood products, and blood sampling when clinically appropriate and permitted by institutional policy. The dual lumen configuration may be useful when separate access channels are needed for compatible therapies, helping clinicians reduce interruptions and improve therapy organization.

Compatibility should always be confirmed with the device instructions for use, facility protocols, medication requirements, catheter access policies, and the clinical judgment of the treating provider. Only appropriate access needles, sterile supplies, and approved infusion equipment should be used with implanted ports.

Usage Guidelines

The Smiths Medical 21-8050-24 dual lumen titanium port should be handled, implanted, accessed, and maintained only by qualified healthcare professionals trained in vascular access procedures. Before use, inspect the product packaging, verify the product code, confirm sterility, and review the manufacturers instructions for use.

During placement, clinicians should follow established sterile technique, anatomical guidance, facility policy, and applicable surgical or interventional procedures. After implantation, port access should be performed using the appropriate non-coring needle and aseptic technique. Each lumen should be identified, flushed, and maintained according to clinical protocol to help reduce the risk of occlusion, infection, or improper therapy administration.

Do not use the device if packaging is damaged, sterility is compromised, product integrity is uncertain, or the device does not match the intended clinical application. Patient assessment, therapy compatibility, and ongoing monitoring should guide all use decisions.

Certifications and Safety Standards

Smiths Medical vascular access products are manufactured for use in regulated healthcare environments and should be used in accordance with applicable medical device standards, institutional policies, and manufacturer instructions. The Smiths Medical 21-8050-24 port infusion device should be stored, handled, and documented according to facility procedures for sterile implantable medical devices.

Clinical teams should confirm all applicable product labeling, regulatory status, expiration dating, lot information, and instructions before use. Any adverse event, device concern, suspected defect, or performance issue should be documented and reported according to facility policy and applicable regulatory requirements.

Comparison with Competitors

Compared with standard single lumen implanted ports, the Smiths Medical 21-8050-24 dual lumen titanium port offers the advantage of two access pathways, which can support more flexible therapy management for appropriate patients. This may be especially useful in clinical settings where separate infusion lines or access channels are preferred.

The titanium port body provides a durable construction profile when compared with some alternative port materials, while the silicone catheter offers flexibility commonly valued in vascular access applications. The detached catheter design can also provide procedural adaptability for clinicians during implantation.

When evaluating this product against competing implanted port systems, buyers should consider lumen configuration, catheter size, port material, placement requirements, access protocols, patient therapy needs, inventory consistency, and compatibility with existing clinical workflows.

Typical User Profile and Application Scenarios

The Smiths Medical 21-8050-24 Port Infusion Dual Lumen Titanium Port with Detached 10.2Fr Silicone Catheter is typically selected by hospitals, oncology centers, infusion departments, vascular access teams, interventional radiology units, and surgical teams that require a reliable implanted access option for appropriate patients.

Common application scenarios include long-term infusion therapy, complex medication schedules, repeated venous access needs, specialty treatment protocols, and care plans that benefit from dual lumen access. It may be used for patients who require dependable vascular access while reducing the need for repeated peripheral venipuncture, subject to physician evaluation and clinical suitability.

Best Practices for Use and Maintenance

To support safe and effective performance, the Smiths Medical 21-8050-24 port should be managed according to manufacturer instructions, evidence-based vascular access practices, and institutional policies. Proper insertion technique, sterile handling, correct needle selection, and consistent maintenance are essential for implanted port care.

• Verify product code, catheter size, packaging integrity, and expiration date before use.
• Use strict aseptic technique during implantation, access, dressing changes, and maintenance.
• Access the port only with an appropriate non-coring needle.
• Flush and lock each lumen according to facility policy and therapy requirements.
• Assess the access site regularly for signs of infection, swelling, leakage, discomfort, or device complications.
• Document access, flushing, medication administration, blood return, patient response, and any unusual findings.
• Follow facility procedures for troubleshooting resistance, occlusion, suspected extravasation, or catheter-related concerns.

Regulatory and Safety Information

The Smiths Medical 21-8050-24 Port Infusion Dual Lumen Titanium Port with Detached 10.2Fr Silicone Catheter is a medical device intended for professional healthcare use. It should not be used by untrained individuals or outside appropriate clinical supervision. Implantation, access, and maintenance require trained personnel, sterile technique, and adherence to the manufacturers instructions for use.

Healthcare providers should evaluate patient suitability, therapy requirements, vascular condition, infection risk, and contraindications before selecting an implanted port system. Any use must comply with applicable federal, state, local, and institutional regulations. Product availability, labeling, and permitted applications may vary, and the official product documentation should always be consulted before clinical use.

How to Order

Select the Smiths Medical 21-8050-24 PORT INFUSION DUAL LUMEN TITANIUM PORT DETACHED 10.2FR SILICONE CATHETER and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.